<SEC-DOCUMENT>0001193125-16-745087-index.html : 20161024
<SEC-HEADER>0001193125-16-745087.hdr.sgml : 20161024
<ACCEPTANCE-DATETIME>20161024160330
ACCESSION NUMBER:		0001193125-16-745087
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20161024
DATE AS OF CHANGE:		20161024
EFFECTIVENESS DATE:		20161024

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HedgePath Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001042418
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				541641133
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-214207
		FILM NUMBER:		161948203

	BUSINESS ADDRESS:	
		STREET 1:		324 SOUTH HYDE PARK AVENUE
		STREET 2:		SUITE 350
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33606
		BUSINESS PHONE:		(813) 864-2559

	MAIL ADDRESS:	
		STREET 1:		324 SOUTH HYDE PARK AVENUE
		STREET 2:		SUITE 350
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33606

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COMMONWEALTH BIOTECHNOLOGIES INC
		DATE OF NAME CHANGE:	19970714
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d269036ds8.htm
<DESCRIPTION>FORM S-8
<TEXT>
Document 1 - file: d269036ds8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d269036dex51.htm
<DESCRIPTION>OPINION OF ELLENOFF GROSSMAN & SCHOLE LLP
<TEXT>
Document 2 - file: d269036dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>d269036dex232.htm
<DESCRIPTION>CONSENT OF CHERRY BEKAERT LLP
<TEXT>
Document 3 - file: d269036dex232.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>d269036dex991.htm
<DESCRIPTION>HEDGEPATH PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN
<TEXT>
Document 4 - file: d269036dex991.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g269036g1014072217096.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g269036g1014072217096.jpg

</DOCUMENT>
</SEC-DOCUMENT>